Skip to main content

TherapeuticsMD, Inc.

TXMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000025743

No open-market purchases or sales by TherapeuticsMD, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $8.10M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in TherapeuticsMD, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
−71 vs. Q1 2022
Shares held
2.08M
−41.5K (−2.0%) vs. Q1 2022Converted for a 1-for-50 split
Total value
$20.3M
−$20.1M (−49.7%) vs. Q1 2022
New holders
11
18 more added
Sold out
82
18 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TXMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 53 institutions
Q1 2021: 162 institutionsQ2 2021: 155 institutionsQ3 2021: 150 institutionsQ4 2021: 132 institutionsQ1 2022: 125 institutionsQ2 2022: 53 institutionsQ3 2022: 43 institutionsQ4 2022: 44 institutionsQ1 2023: 41 institutionsQ2 2023: 42 institutionsQ3 2023: 36 institutionsQ4 2023: 39 institutionsQ1 2024: 43 institutionsQ2 2024: 38 institutionsQ3 2024: 37 institutionsQ4 2024: 41 institutionsQ1 2025: 42 institutionsQ2 2025: 42 institutionsQ3 2025: 46 institutionsQ4 2025: 44 institutionsQ1 2026: 49 institutionsQ2 2026: 44 institutions
Value heldQ2 2022: $20.3M
Q1 2021: $237.0MQ2 2021: $203.9MQ3 2021: $98.2MQ4 2021: $44.1MQ1 2022: $40.4MQ2 2022: $20.3MQ3 2022: $13.8MQ4 2022: $19.4MQ1 2023: $11.7MQ2 2023: $12.5MQ3 2023: $9.02MQ4 2023: $7.32MQ1 2024: $7.73MQ2 2024: $5.49MQ3 2024: $5.61MQ4 2024: $3.03MQ1 2025: $3.09MQ2 2025: $3.78MQ3 2025: $3.54MQ4 2025: $5.52MQ1 2026: $7.94MQ2 2026: $8.10M
Institutions holding TXMD and their total value by quarter
QuarterHoldersValue
Q2 202644$8.10M
Q1 202649$7.94M
Q4 202544$5.52M
Q3 202546$3.54M
Q2 202542$3.78M
Q1 202542$3.09M
Q4 202441$3.03M
Q3 202437$5.61M
Q2 202438$5.49M
Q1 202443$7.73M
Q4 202339$7.32M
Q3 202336$9.02M
Q2 202342$12.5M
Q1 202341$11.7M
Q4 202244$19.4M
Q3 202243$13.8M
Q2 202253$20.3M
Q1 2022125$40.4M
Q4 2021132$44.1M
Q3 2021150$98.2M
Q2 2021155$203.9M
Q1 2021162$237.0M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding TherapeuticsMD, Inc.; share changes are against Q1 2022.

Institutions holding TXMD in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Victory Capital Management Inc0$00.00%−1,142−100.0%Sold outConverted for a 1-for-50 split
Moors & Cabot, Inc.0$00.00%−610−100.0%Sold outConverted for a 1-for-50 split
Long Run Wealth Advisors, LLC0$00.00%−611−100.0%Sold outConverted for a 1-for-50 split
Ameritas Investment Partners, Inc.0$00.00%−549−100.0%Sold outConverted for a 1-for-50 split
Affiance Financial, LLC0$00.00%−501−100.0%Sold outConverted for a 1-for-50 split
Prudential Financial Inc0$00.00%−479−100.0%Sold outConverted for a 1-for-50 split
Apeiron RIA LLC0$00.00%−553−100.0%Sold outConverted for a 1-for-50 split
TCWP LLC0$00.00%−520−100.0%Sold outConverted for a 1-for-50 split
Cambridge Investment Research Advisors, Inc.0$00.00%−432−100.0%Sold outConverted for a 1-for-50 split
Jane Street Group, LLC0$00.00%−382−100.0%Sold outConverted for a 1-for-50 split
Xponance, Inc.0$00.00%−371−100.0%Sold outConverted for a 1-for-50 split
Moneta Group Investment Advisors LLC0$00.00%−6−100.0%Sold outConverted for a 1-for-50 split
Apollon Wealth Management, LLC0$00.00%−300−100.0%Sold outConverted for a 1-for-50 split
Tobias Financial Advisors, Inc.0$00.00%−320−100.0%Sold outConverted for a 1-for-50 split
J.W. Cole Advisors, Inc.0$00.00%−239−100.0%Sold outConverted for a 1-for-50 split
Personal Capital Advisors Corp0$00.00%−260−100.0%Sold outConverted for a 1-for-50 split
Oppenheimer & Co Inc0$00.00%−244−100.0%Sold outConverted for a 1-for-50 split
Profund Advisors LLC0$00.00%−230−100.0%Sold outConverted for a 1-for-50 split
Guggenheim Capital LLC0$00.00%−214−100.0%Sold outConverted for a 1-for-50 split
Avidian Wealth Solutions, LLC0$00.00%−217−100.0%Sold outConverted for a 1-for-50 split
Mirae Asset Global Investments Co., Ltd.0$00.00%−212−100.0%Sold outConverted for a 1-for-50 split
Stratos Wealth Partners, LTD.0$00.00%−202−100.0%Sold outConverted for a 1-for-50 split
Altium Wealth Management LLC0$00.00%−200−100.0%Sold outConverted for a 1-for-50 split
Magnolia Capital Advisors LLC0$00.00%−202−100.0%Sold outConverted for a 1-for-50 split
Silverlake Wealth Management LLC0$00.00%−200−100.0%Sold outConverted for a 1-for-50 split
Calton & Associates, Inc.0$00.00%−200−100.0%Sold outConverted for a 1-for-50 split
DFPG Investments, LLC0$00.00%−200−100.0%Sold outConverted for a 1-for-50 split
Money Concepts Capital Corp0$00.00%−27−100.0%Sold outConverted for a 1-for-50 split
Quantbot Technologies LP0$00.00%−64−100.0%Sold outConverted for a 1-for-50 split
Baron Financial Group, LLC0$00.00%−16−100.0%Sold outConverted for a 1-for-50 split
Howe & Rusling Inc0$00.00%−20−100.0%Sold outConverted for a 1-for-50 split
Daiwa Securities Group Inc.0$00.00%−12−100.0%Sold outConverted for a 1-for-50 split
TCI Wealth Advisors, Inc.0$00.00%−26−100.0%Sold outConverted for a 1-for-50 split
PrairieView Partners, LLC0$00.00%−1−100.0%Sold outConverted for a 1-for-50 split
Mackenzie Financial Corp0$00.00%−424−100.0%Sold outConverted for a 1-for-50 split
Amalgamated Financial Corp.––––Not filed